Senna and Ozempic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Senna (senna) and Ozempic (semaglutide). Common drug interactions include eye infection among females and ischaemic stroke among males.

The phase IV clinical study analyzes what interactions people have when they take Senna and Ozempic. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Senna?

Senna has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 37,302 Senna users. Check the latest studies of Senna.

What is Ozempic?

Ozempic has active ingredients of semaglutide. It is often used in weight loss. eHealthMe is studying from 29,762 Ozempic users. Check the latest studies of Ozempic.



On Aug, 13, 2026

67 people who take Senna and Ozempic together, and have interactions are studied.

Senna and Ozempic drug interactions.

What are the common drug interactions of Senna and Ozempic, by gender? *:

female:

  1. Eye infection
  2. Fungal infection
  3. Hyperaesthesia
  4. Infusion site haemorrhage (bleeding from infusion site)
  5. Infusion site pain
  6. Insomnia (sleeplessness)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Migraine (headache)
  9. Phlebitis (inflammation of the walls of a vein)
  10. Post procedural infection

male:

  1. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  2. Hospitalisation
  3. Abscess limb (limb infection)
  4. Asthenia (weakness)
  5. Cellulitis (infection under the skin)
  6. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  7. Chills (felling of cold)
  8. Chronic kidney disease
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Colon gangrene (colon tissue dies)

What are the common drug interactions of Senna and Ozempic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  2. White blood cell count increased

40-49:

  1. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  2. Chronic kidney disease
  3. Colon gangrene (colon tissue dies)
  4. Deformity (disfigurement)
  5. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  6. Infected dermal cyst
  7. Necrosis (the death of body tissue)
  8. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  9. Nerve injury
  10. Pain

50-59:

  1. Hospitalisation
  2. Abdominal abscess (collection of pus in abdomen)
  3. Abdominal discomfort
  4. Fatigue (feeling of tiredness)
  5. International normalised ratio increased
  6. Abscess limb (limb infection)
  7. Acute respiratory failure
  8. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  9. Asthenia (weakness)
  10. Chills (felling of cold)

60+:

  1. Acute sinusitis
  2. Appendicitis (inflammation of the appendix)
  3. Injection site pain
  4. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  5. Iron deficiency anaemia
  6. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  7. Pain in extremity
  8. Sinusitis (inflammation of sinus)
  9. Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 19 people, 28.36%
  2. High Blood Pressure: 18 people, 26.87%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 16 people, 23.88%
  4. Pain In Extremity: 13 people, 19.40%
  5. Joint Pain: 13 people, 19.40%
  6. Pain: 12 people, 17.91%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 16.42%
  8. Diabetes: 10 people, 14.93%
  9. Immunodeficiency Common Variable: 10 people, 14.93%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 10 people, 14.93%

* Approximation only. Some reports may have incomplete information.

Do you take Senna and Ozempic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Senna and Ozempic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Senna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ozempic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Senna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ozempic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on senna and semaglutide (the active ingredients of Senna and Ozempic, respectively), and Senna and Ozempic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: